February 6, 2019

The Early Diagnosis of Alzheimer’s Disease: Exploring a Patient with Memory Complaints and Identifying Underlying Pathologies

Alzheimer’s Association International Conference 2018

Managing the Case Following Diagnosis

Miia Kivipelto, MD, PhD, describes the value of an early diagnosis of Alzheimer’s disease alongside the disclosure of diagnosis and clinical management options for a patient who has been diagnosed with Alzheimer’s disease in the early stages. She also provides preliminary results from non-pharmacological intervention studies and describes the potential role of these interventions in the patient case study.

Download Key Learnings

Summary of key learnings from Biogen’s AAIC 2018 Symposium

Key Learning Objectives for Biogen’s AAIC 2018 Symposium:

  • Understand the importance and challenges of an early diagnosis of Alzheimer’s disease
  • Broaden understanding of the use of neuropsychological tools and imaging and fluid biomarkers to leverage an earlier diagnosis of Alzheimer’s disease
  • Highlight the value of biomarkers for assessing differential diagnosis across dementia etiologies
  • Explore clinical management options for patients with a diagnosis of Alzheimer’s disease in the early stages, including current non-pharmacological interventions

Disclosure: All panelists received honoraria from Biogen for participation in this symposium.

Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.